{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T05:59:45Z","timestamp":1670997585622},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00508-022-02067-2","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T13:03:47Z","timestamp":1660136627000},"page":"828-830","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["At what frequency of vaccination do the vaccinated potentially pose an equal risk to the unvaccinated for transmission of SARS-CoV-2 inside restaurants in New York City?"],"prefix":"10.1007","volume":"134","author":[{"given":"Gary P.","family":"Wormser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Visintainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.26.21264142","author":"MJ Ahlers","year":"2021","unstructured":"Ahlers\u00a0MJ, Aralis\u00a0HJ, Tang\u00a0WL, Sussman\u00a0JB, Fonarow\u00a0GC, Ziaeian\u00a0B. Non-pharmaceutical interventions and COVID-19 burden in the United States. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.09.26.21264142.","journal-title":"medRxiv"},{"key":"2067_CR2","unstructured":"COVID-19 breakthrough data\/Department of Health. https:\/\/coronavirus.health.ny.gov\/covid-19-breakthrough-data. Accessed 22 May 2022."},{"key":"2067_CR3","unstructured":"Varma J. Keep indoor vax rules, NYC: Why Adams is wrong to drop COVID shot proof for restaurants, museums and more. New York Daily News, March 3, 2022."},{"issue":"1","key":"2067_CR4","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1038\/s41467-021-26154-6","volume":"12","author":"F Rovida","year":"2021","unstructured":"Rovida\u00a0F, Cassaniti\u00a0I, Paolucci\u00a0S, Percivalle\u00a0E, Sarasini\u00a0A, Piralla\u00a0A, et\u00a0al. SARS-CoV\u20112 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers. Nat Commun. 2021;12(1):6032. https:\/\/doi.org\/10.1038\/s41467-021-26154-6.","journal-title":"Nat Commun"},{"issue":"4","key":"2067_CR5","doi-asserted-by":"publisher","first-page":"612.e1","DOI":"10.1016\/j.cmi.2021.11.010","volume":"28","author":"PY Chia","year":"2021","unstructured":"Chia\u00a0PY, Ong\u00a0SWX, Chiew\u00a0CJ, Ang\u00a0LW, Chavatte\u00a0JM, Mak\u00a0TM, et\u00a0al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study. Clin Microbiol Infect. 2022;28(4):612.e1\u2013612.e7. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.010.","journal-title":"Clin Microbiol Infect"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/cid\/ciab229","volume":"74","author":"AJ Tande","year":"2022","unstructured":"Tande\u00a0AJ, Pollock\u00a0BD, Shah\u00a0ND, Farrugia\u00a0G, Virk\u00a0A, Swift\u00a0M, et al. Impact of the coronavirus disease 2019 (COVID-19) vaccine on asymptomatic infection among patients undergoing preprocedural COVID-19 molecular screening. Clin Infect Dis. 2022;74:59\u201365.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2067_CR7","doi-asserted-by":"publisher","first-page":"ofac135","DOI":"10.1093\/ofid\/ofac135","volume":"9","author":"CB Acharya","year":"2022","unstructured":"Acharya\u00a0CB, Schrom\u00a0J, Mitchell\u00a0AM, Coil\u00a0DA, Marquez\u00a0C, Rojas\u00a0S, et al. Viral load among vaccinated and unvaccinated, asymptomatic and symptomatic persons infected with SARS-CoV\u20112 delta variant. Open Forum Infect Dis. 2022;9(5):ofac135. https:\/\/doi.org\/10.1093\/ofid\/ofac135.","journal-title":"Open Forum Infect Dis"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","volume":"22","author":"A Singanayagam","year":"2022","unstructured":"Singanayagam\u00a0A, Hakki\u00a0S, Dunning\u00a0J, Madon\u00a0KJ, Crone\u00a0MA, Koycheva\u00a0A, et al. Community transmission and viral load kinetics of the SARS-CoV\u20112 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a\u00a0prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22:183\u201395.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2067_CR9","doi-asserted-by":"publisher","first-page":"ofac066","DOI":"10.1093\/ofid\/ofac066","volume":"9","author":"CT Bramante","year":"2022","unstructured":"Bramante\u00a0CT, Proper\u00a0JL, Boulware\u00a0DR, Karger\u00a0AB, Murray\u00a0T, Rao\u00a0V, et al. Vaccination against SARS-CoV\u20112 is associated with a\u00a0lower viral load and likelihood of systemic symptoms. Open Forum Infect Dis. 2022;9(5):ofac66. https:\/\/doi.org\/10.1093\/ofid\/ofac066.","journal-title":"Open Forum Infect Dis"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1126\/science.abf9569","volume":"371","author":"AL Rasmussen","year":"2021","unstructured":"Rasmussen\u00a0AL, Popescu\u00a0SV. SARS-CoV\u20112 transmission without symptoms. Symptomless transmission silently drives spread and is key to ending the pandemic. Science. 2021;371:1206\u20137.","journal-title":"Science"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1056\/NEJMe2203329","volume":"386","author":"PA Offit","year":"2022","unstructured":"Offit\u00a0PA. Covid-19 boosters\u2014Where from here? N\u00a0Engl J Med. 2022;386:1661\u20132.","journal-title":"N Engl J Med"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S1473-3099(21)00690-3","volume":"22","author":"A Wilder-Smith","year":"2022","unstructured":"Wilder-Smith\u00a0A. What is the vaccine effect on reducing transmision in the context of the SARS-CoV\u20112 delta variant? Lancet Infect Dis. 2022;22:152\u20133.","journal-title":"Lancet Infect Dis"},{"key":"2067_CR13","doi-asserted-by":"publisher","unstructured":"Plesner Lyngse\u00a0F, Hvas Mortensen\u00a0L, Denwood\u00a0MJ, Engbo Christiansen\u00a0L, Holten Moller\u00a0C, Skov\u00a0LR, et al. SARS-CoV\u20112 Omicron VOC transmission in Danish households. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.12.27.21268278. preprint.","DOI":"10.1101\/2021.12.27.21268278"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-022-02067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-022-02067-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-022-02067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T16:25:13Z","timestamp":1670948713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-022-02067-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":13,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s00508-022-02067-2","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.P.\u00a0Wormser reports receiving research grants from the Institute for Systems Biology, Biopeptides, Corp., and Pfizer, Inc. He has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the non-profit American Lyme Disease Foundation. P.\u00a0Visintainer declares that he has no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}